Product information and disease descriptionProduct descriptionProduct information
Dosage forms and strengths
1 evidence topic · 1 source
Investigational formulation concentration in the GALLOP protocol
Material safety data sheet
No evidence found.
Imsidolimab
Generalized pustular psoriasis
- Manufacturer
- Vanda Pharmaceuticals
- Regulatory submission
- BLA submitted December 2025
- Last updated